Integrated or Independent Actions of Metformin in Target Tissues Underlying Its Current Use and New Possible Applications in the Endocrine and Metabolic Disorder Area
Metformin is considered the first-choice drug for type 2 diabetes treatment. Actually, pleiotropic effects of metformin have been recognized, and there is evidence that this drug may have a favorable impact on health beyond its glucose-lowering activity. In summary, despite its long history, metform...
Main Author: | Giovanni Tulipano |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/23/13068 |
Similar Items
-
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine Tumors
by: Claudio Vernieri, et al.
Published: (2019-09-01) -
How treatments with endocrine and metabolic drugs influence pituitary cell function
by: Giovanni Tulipano
Published: (2020-02-01) -
Butyrate and Metformin Affect Energy Metabolism Independently of the Metabolic Phenotype in the Tumor Therapy Model
by: Felix B. Meyer, et al.
Published: (2021-12-01) -
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
by: Eleonora Vitali, et al.
Published: (2020-08-01) -
Metabolic Action of Metformin
by: Izabela Szymczak-Pajor, et al.
Published: (2022-06-01)